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Background: When new space-occupying lesions are observed together with peripheral blood eosinophilia in
patients diagnosed with cancer, the possibility of eosinophilic organ involvement should be differentiated from
metastasis of primary cancer, since a misdiagnosis could lead to unnecessary chemotherapy. The aim of this study
is to identify the clinical characteristics of eosinophilic organ involvement that distinguish it from distant metastasis
in patients with primary cancer.
Methods: The medical records of 43 cancer patients who developed hepatic or pulmonary nodules with peripheral
blood eosinophilia between January 2005 and February 2010 in the Asan Medical Center (Seoul) were reviewed.
Eosinophilic infiltration and distant metastasis were identified on the basis of pathological findings and radiological
features. Fisher’s exact test, χ2 test or Mann-Whitney test were used for statistical analysis.
Results: In total, 33 patients (76%) were diagnosed with eosinophilic infiltration, 5 (12%) with cancer metastasis and
5 (12%) had undetermined diagnoses. Compared to the patients with metastases, the patients with eosinophilic
infiltration were significantly more likely to have serology indicating a parasitic infection, a history of eating raw
food, high serum levels of total IgE, normal liver function, normal C-reactive protein levels, a normal erythrocyte
sedimentation rate, and fewer and smaller nodules. The most common underlying malignancy in the eosinophilic
organ infiltration group was stomach cancer. Physicians tended to neglect the eosinophilia in patients with a
history of cancer.
Conclusions: Several clinical characteristics of eosinophilic organ infiltration distinguish it from cancer metastasis.
Physicians should make greater efforts to determine the causes of organ involvement with peripheral blood
eosinophilia, especially in cancer patients.
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Eosinophilic organ infiltration often damages target
organs and induces their dysfunction by releasing cyto-
toxic granule proteins and inflammatory lipid mediators
and promoting thromboembolic phenomena [1,2]. Even
though eosinophilic expansion is secondary to an* Correspondence: allergy@medimail.co.kr
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reproduction in any medium, provided the oridentifiable disease (such as parasitic infection, drug
hypersensitivity, allergic diseases, collagen vascular dis-
eases and internal malignancies), the damage it can
cause by organ infiltration can affect various organ sys-
tems, including the skin, lung, liver, brain and, most im-
portantly, the heart [3-6]. However, most cases of
eosinophilic organ infiltration can be cured easily by cor-
recting the underlying cause of the eosinophilia [7].
One particularly challenging problem in clinical prac-
tice is when a patient with cancer develops eosinophilic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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organ infiltration can mimic those of cancer metastasis,
it can lead to a misdiagnosis and unnecessary anti-
cancer therapy. Indeed, misdiagnoses of eosinophilic
abscesses as metastases have been described in anecdotal
case reports [8-12].
Several reports describe how to identify eosinophilic
organ infiltration by radiology [13-20]. However, the
clinical characteristics of eosinophilic organ infiltration
in patients with a history of cancer have not been
researched previously. This is important because this in-
formation could aid the management of patients with a
history of cancer who present with a newly developed
nodule and peripheral eosinophilia.
In this study, patients with a history of cancer who
developed new nodules in the liver or lung and exhib-
ited peripheral eosinophilia were identified retrospect-
ively. The clinical characteristics of eosinophilic organ
involvement that distinguished it from metastasis were
then determined. In addition, the diagnostic trials that
were performed by the physicians to determine the




The medical records of patients who visited or were ad-
mitted to the Asan Medical Center (Seoul) between 1
January 2005 and 28 February 2010 were assessed using
the International Statistical Classification of Diseases
and Related Health Problems, 10th Revision (ICD-10).
The patients whose ICD-10 codes included both D 721
(eosinophilia) and C*(C 000 – C 999: any malignant dis-
ease) were selected (n = 141) (Figure 1). The records of
these patients were then meticulously reviewed for the
presence of peripheral eosinophilia and new nodules in
the liver or lung of cancer patients who had been or
were being treated with anti-cancer therapy (operation
or chemotherapy). Of the 141 patients, 98 were excludedFigure 1 Selection of the cases for the final analysis.because of the absence of new nodules. The remaining
43 patients with a history of malignancy had both per-
ipheral eosinophilia and newly developed nodules in the
liver or lung (Figure 1).
Study design
Demographic and clinical data, namely age, sex, dur-
ation of cancer, type of cancer, a history of eating raw
foods, radiological data [the organ involved (liver and/
or lung), the number of nodules in the involved organs
and the diameter of the largest nodule] and laboratory
data [liver function test results, eosinophil count, total
IgE level, C-reactive protein (CRP) level, erythrocyte
sedimentation rate (ESR), presence of parasite ova in
the stools and parasite serology], were collected. Para-
site serology was performed for Paragonimus wester-
mani, Clonorchis sinensis, sparganosis, cysticercosis and
toxocariasis by using enzyme-linked immunosorbent
assays (ELISA).
Based on the pathological, radiological and clinical fea-
tures of the new nodules in the liver or lung, the patients
were grouped into the eosinophilic abscess group, the
malignant nodule group or the undetermined diagnosis
group (Figure 1). An eosinophilic abscess was defined as
a biopsy-proven (including operative resection) eosino-
philic abscess or a clinically eosinophilic abscess. A
clinically eosinophilic abscess was diagnosed when all
of the following conditions were satisfied: (1) the bi-
opsy was not diagnostic or was not performed, and
(2) serial enhanced computed tomography (CT) or
ultrasonography imaging studies revealed the dis-
appearance or spontaneous regression of the initially
identified poorly circumscribed low-attenuation lesion
(on CT) or low-echoic lesion (on US) that had been
diagnosed by the radiologist as an eosinophilic abscess.
Malignant nodules were defined as biopsy-proven (in-
cluding operative resection) malignancies or as clinic-
ally malignant nodules. A clinically malignant nodule
was diagnosed when all of the following conditions
Table 1 Demographic data of cases with eosinophilic








Age, years 54.6 ± 9.9 61.2 ± 16.2 0.243
Sex 1.000
Male 78 (26/33) 80 (4/5)
Female 22 (7/33) 20 (1/5)
Duration since diagnosis
of cancer, years
2.4 ± 2.3 0.8 ± 1.3 0.182
History of eating raw food 0.048
Present 36 (12/33) 0 (0/5)
Absent 6 (2/33) 40 (2/5)
Unknown 58 (19/33) 60 (3/5)
The data are presented as means ± SD or percentages (number of patients).
The P-values were determined by the Mann–Whitney U-test, chi-square or
Fisher’s test.
Table 2 Radiological data of cases with eosinophilic








Organ that was involved 0.599
Liver only 85 (28/33) 80 (4/5)
Lung only 6 (2/33) 20 (1/5)
Liver and lung 9 (3/33) 0 (0/5)
Nodules in the organs
involved, number
3.9 ± 3.6 14.2 ± 8.6 0.017
Diameter of the largest
nodule, cm
1.6 ± 0.6 6.2 ± 3.4 0.013
Duration of the nodules,
months
10.0 ± 8.9
Status of the nodule(s) in
a follow-up study,
< 0.001
Totally disappeared 91 (30/33) 20 (1/5)*
Decreased 9 (3/33) 0 (0/5)
Increased 0 (0/33) 80 (4/5)
*Operative resection was performed in the case where the malignant nodule
disappeared.
The data are presented as means ± SD or percentages (number of patients).
The P-values were determined by the Mann-Whitney U-test, chi-square or
Fisher’s test.
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was not performed, and (2) serial CT or US studies
revealed the progression of the initially identified well-
circumscribed low-attenuation lesion (on CT) or low-
echoic lesion (on US) that had been diagnosed by the
radiologist as a malignancy (or, in the case of patients
who expired before follow-up imaging studies could
be performed, a single imaging study that led the
radiologist to diagnose the lesion as a malignancy).
The nodule was classified as “undetermined” if any of
these criteria were not met.
The eosinophilic abscess and malignant nodule
groups were also subdivided according to the probable
cause of eosinophilia, namely (1) a parasite, (2) a drug
(such as antibiotics or chemotherapeutic agents) and
(3) unknown (this included cancer-induced eosino-
philia). A parasitic etiology was selected as the cause
when the following two conditions were satisfied: (1)
the parasite serology returned a positive result, ova
were observed in the stools, or there were high total
IgE levels plus a history of eating raw foods, and (2)
there was no other possible cause such as drugs. A
drug etiology was selected when the eosinophilia devel-
oped within 4 weeks of drug exposure and there was
no historical or laboratory evidence of a parasite infec-
tion. An unknown etiology was selected if (1) the
cause was not known despite sufficient history-taking
and laboratory testing or (2) the history-taking and la-
boratory testing were not sufficient for elucidating the
cause of eosinophilia.
Finally, the diagnostic trials that were performed by
the physicians to identify the causes of the eosinophilia
and organ nodules were assessed. The trials were
deemed ‘adequate’ if the physicians had asked about the
history of eating raw foods and had ordered blood tests
such as parasite ELISAs. The trials were deemed ‘inad-
equate’ if the physician had not asked about the history
of eating raw foods and had not ordered blood tests such
as parasite ELISAs.
Statistical methods
Fisher’s exact test and χ2 test were performed for cat-
egorical variables, and the Mann-Whitney test was car-
ried out for continuous variables. P < 0.05 was
considered to indicate statistical significance.
Results and discussion
Of the 43 patients with a history of cancer who dis-
played a new nodule(s) in the liver or lung along with
eosinophilia, 33 were diagnosed with an eosinophilic ab-
scess (5, biopsy-proven; 28, clinically) and 5 with a ma-
lignant nodule (2, biopsy proven; 3, clinically). The
diagnosis of the remaining five patients could not be
determined, and their data were excluded from furtheranalysis. The eosinophilic abscess and malignant nodule
groups did not differ significantly in terms of age, sex,
duration after the cancer diagnosis and the organ
involved (Tables 1 and 2). However, the patients with an
eosinophilic abscess were more likely to have a history
of eating raw food than the patients with malignant
nodules (36% vs. 0%, p= 0.048). In addition, the eosino-
philic abscess group had significantly fewer nodules than
the malignant nodule group (3.9 ± 3.6 vs. 14.2 ± 8.6,
p= 0.017). The nodules in the eosinophilic abscess group
Table 3 Laboratory data of cases of eosinophilic








Blood eosinophils, number/ul 1,808.6 ± 1,625.8 4,186± 4,053.7 0.160
Blood eosinophils, % 20.0 ± 11.2 31.6 ± 21.0 0.243
Severity of eosinophilia, 0.060
Mild (450–1,500/ul) 52 (17/33) 40 (2/5)
Moderate (1,500–5,000/ul) 45 (15/33) 20 (1/5)




Log total IgE 7.4 ± 1.4 4.9 ± 1.2 0.021
AST, IU/l 26.6 ± 12.9 112.60± 100.0 0.002
ALT, IU/l 22.7 ± 18.7 80.0 ± 47.4 0.002
Alkaline phosphatase, IU/l 76.4 ± 23.1 460.0 ± 509.8 0.019
Bilirubin, total, mg/dl 0.9 ± 0.4 5.2 ± 8.3 0.002
C-reactive protein, mg/dl 0.8 ± 0.9 10.8 ± 12.8 0.004
Erythrocyte sedimentation
rate, mm/h
31.3 ± 19.1 102.5 ± 24.8 0.040
The data are presented as means ± SD or number (%).
The P-values are determined by the Mann-Whitney U-test, chi-square or
Fisher’s test.
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nant nodule group (1.6 ± 0.6 vs. 6.2 ± 3.4 cm, p= 0.013).
As expected, given the definitions of the two groups
(see Materials and Methods), the nodules of the eo-
sinophilic group either disappeared or decreased upon
a follow-up imaging study, while the nodules of the
malignant nodule group grew (Table 2). In one of the
patients in the malignant nodule group, the eosino-
philia and nodule disappeared at the same time,
namely, the eosinophilia resolved when the nodule was
resected.
The eosinophilic abscess group had significantly higher
serum total IgE levels than the malignant nodule groupFigure 2 The types of underlying malignancy in the eosinophilic absc(7.4 ± 1.4 vs. 4.9 ± 1.2 log IgE, p= 0.021) (Table 3). The eo-
sinophilic abscess group also had significantly lower liver
function test results [AST (aspartate transaminase), ALT
(alanine transaminase), alkaline phosphatase and total
bilirubin] and CRP and ESR levels than the malignant nod-
ule group: AST (26.6 ± 12.9 IU/l vs. 112.60 ± 100.0 IU/l,
p= 0.002), ALT (22.7 ± 18.7 IU/l vs. 80.0 ± 47.4 IU/l,
p = 0.002), alkaline phosphatase (76.4 ± 23.1 IU/l vs.
460.0 ± 509.8 IU/l, p= 0.019), total bilirubin (0.9 ± 0.4
mg/dl vs. 5.2 ± 8.3 mg/dl, p= 0.002), CRP (0.8 ± 0.9 mg/dl
vs. 10.8 ± 12.8, p= 0.004), and ESR (31.3 ± 19.1 mm/h vs.
102.5 ± 24.8 mm/h, p= 0.040) (Table 3).
Stomach cancer was the most common malignant dis-
ease that was associated with eosinophilic abscess [46%
(15/33)]. The other underlying malignancies in the
patients with eosinophilic abscess were, in order of fre-
quency, colorectal cancer, hepatocellular carcinoma and
lung cancer (Figure 2).
The diagnosis of an eosinophilic abscess required that
it eventually regressed. An analysis of the relationship be-
tween the disappearance of both the nodule and the eo-
sinophilia in eosinophilic abscess patients revealed that
the peripheral eosinophilia was more likely to normalize
at the same time that the eosinophilic abscess disap-
peared rather than before or after (Figure 3).
The cause of eosinophilia was most often unknown in
both groups, mainly because of incomplete history taking
and workup (Figure 4): in the eosinophilic abscess group,
the causes were either undetermined (n= 19) or due to a
parasite (n= 14) (none of the patients had a drug-related
cause); in the malignant nodule group, the causes were
undetermined in four patients and due to a drug in the
remaining patient. Thus, a parasite was significantly
more frequently the cause of eosinophilia in the eosino-
philic abscess group than in the malignant nodule group
[42% (14/33) vs. 0% (0/5), p= 0.04] (Figure 4).
The degree of effort made by the physicians to de-
termine the cause of eosinophilia was most frequently
‘inadequate’ in both groups [eosinophilic abscess group,ess and malignant nodule groups.
Figure 3 Resolution of eosinophilia in the eosinophilic abscess.
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p= 0.574] (Figure 5).
The present study showed that eosinophilic organ in-
filtration can be distinguished from metastasis in cancer
patients with eosinophilia on the basis of several clinical
characteristics. First, parasite infestation was a significant
cause of eosinophilic organ infiltration. Many patients
with eosinophilic organ infiltration had a history of eat-
ing raw meat and had high total IgE levels and positive
parasite ELISA results, unlike the malignant nodule
group patients. In Korea, there is a custom of ingesting
raw cow liver, which is a reservoir for the encapsulated
larvae of Toxocara cani; consequently, ingestion of raw
cow liver induces human toxocariasis [14,15]. The direct
parasite invasion in toxocariasis results in the ensuing
eosinophilia. Toxocara cani, along with other parasites
such as trematodes, also generate focal lesions in the
hepatic parenchyma, either by directly penetrating the
liver or via hematogenous migration to the liver [20].
These lesions are caused by arrested immature worms
and thus contain worms. Parasite-induced secondary eo-
sinophilia more frequently involves the liver or lung than
the heart, skin or nervous system and seems to induce
nodules in those organs [8-13,15-20,22,23].
The second clinical feature that distinguishes eosino-
philic organ infiltration from malignant nodules is one
that was used to diagnose the patients in this study,
namely, the different radiological findings. Thus, on CT
or US, the eosinophilic infiltrations and the malignant
nodules are both depicted as low-attenuation or low-
echoic lesions, respectively. However, the eosinophilicFigure 4 Presumptive etiology of the eosinophilia in the eosinophilicabscesses are poorly demarcated, multifocal, and small
(< 2 cm) and either disappear or regress considerably
upon subsequent CT or US imaging studies. In contrast,
the malignant nodules are well circumscribed, signifi-
cantly larger and generally progress. These findings are
consistent with those of previous studies [18,20]. In
addition, the present study found that while the hepatic
eosinophilic infiltrations were multifocal, there were far
fewer nodules than in malignant nodule group patients.
The mean duration of eosinophilic infiltration was about
10 months, and the nodules tended to disappear at the
same time that the eosinophilia normalized.
The third clinical feature that distinguishes eosino-
philic infiltrations was that the liver functions and CRP
and ESR levels were significantly lower (namely within
normal limits) in the eosinophilic infiltration patients
than in the patients with malignant nodules. It seems
that the eosinophils destroy the hepatic parenchyma less
profoundly than malignant cells.
Fourth, the most common underlying malignancy in
patients with eosinophilic organ infiltration was stomach
cancer. This was also observed in another study [24]. Al-
though the reason for this is not clear, some tumors are
known to produce eosinophilotactic factors [21]. It may
be that stomach cancer cells produce particularly large
amounts of such factors.
Lastly, we observed that the physicians tended to neg-
lect the eosinophilia in patients with history of a cancer,
as the degree of effort made by the physicians to deter-
mine the cause of the eosinophilia was largely inad-
equate. This could result in the misdiagnosis of anabscess and malignant nodule groups.
Figure 5 The degree of effort to find out the cause of eosinophilia in the eosinophilic abscess and malignant nodule groups.
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turn could lead to unnecessary chemotherapy. In fact,
we have observed the case of a patient who had an eo-
sinophilic abscess that was indeed misdiagnosed as a
relapsed malignancy (unpublished observation). Given
that eosinophilic organ infiltration can be cured easily
by correcting the underlying etiology of the eosinophilia
without unnecessary chemotherapy [7], our observation
suggests that physicians should make a greater effort to
determine the cause of eosinophilia, especially in cancer
patients who have both new nodules and peripheral
eosinophilia.
The present study had some limitations. First, the
eosinophilic abscess was not pathologically proven in
all patients. However, in cases where there was no
histological proof, the disease was diagnosed on the
basis of the characteristic imaging features of eosino-
philic abscesses and follow-up imaging studies that
showed that the lesions regressed partially or com-
pletely. Second, the study had a retrospective design.
Therefore, there were many missing values, and this
made the statistical analysis difficult. Third, since the
malignant nodule group (n = 5) was too small for
proper comparison with the eosinophilic abscess
group (n = 33), the results should be interpreted cau-
tiously. Another large-sized study is required to con-
firm these results.Conclusion
This study is the first to report the clinical character-
istics that may distinguish eosinophilic organ involve-
ment from metastasis in cancer patients with
eosinophilia. It also shows that physicians should
make greater efforts to determine the cause of eo-
sinophilia in such patients, especially those who have
both new nodules and peripheral eosinophilia. This would
obviate the chance of unnecessary chemotherapy. More-
over, most cases of eosinophilic organ infiltration can be
cured easily by correcting the etiology underlying the
eosinophilia.Consent
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